v3.26.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities          
Net loss $ (131,005) $ (171,897) $ (248,509) $ (374,384)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     37,840 43,180  
Stock-based compensation     41,713 62,217  
Asset impairment     0 5,956  
Lease expense     10,459 11,755  
Loss on disposal of a business     0 4,502  
Deferred income taxes     (4,600) 219  
Other, net     2,414 8,879  
Changes in operating assets and liabilities:          
Other receivables and assets     8,454 30,246  
Prepaid data assets     3,062 29,601  
Accrued data liability     0 20,258  
Unearned revenue     (9,552) (23,383)  
Accounts payable     (5,602) (1,145)  
Accrued development expense     (814) (155)  
Accrued expenses and other current liabilities     (12,623) (15,213)  
Lease liabilities     (9,290) (10,908)  
Net cash used in operating activities     (187,048) (208,375)  
Cash flows from investing activities          
Purchases of property and equipment     (302) (4,982)  
Purchase of an intangible asset     (1,995) (2,158)  
Decrease in cash related to disposal of a business     0 (4,438)  
Purchases of investments     0 (1,500)  
Net cash used in investing activities     (2,297) (13,078)  
Cash flows from financing activities          
Proceeds from issuance of common shares, net of issuance costs     0 141,024  
Equity incentive plans     (278) 4,293  
Repayment of long-term debt and finance lease liabilities     (4,459) (4,131)  
Purchase of an intangible asset     0 (3,000)  
Net cash provided by (used in) financing activities     (4,737) 138,186  
Effect of exchange rate changes on cash, cash equivalents and restricted cash     (3,019) 14,088  
Net change in cash, cash equivalents and restricted cash     (197,101) (69,179)  
Cash, cash equivalents and restricted cash, beginning of period     753,921 603,024 $ 603,024
Cash, cash equivalents and restricted cash, end of period $ 556,820 $ 533,845 556,820 533,845 $ 753,921
Supplemental schedule of non-cash investing and financing activities          
Accrued property and equipment     300 263  
Purchase of an equity investment     $ 0 $ 4,438